Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851

May 2, 2026 - 13:00

Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851

Tags:

Previous Article

Here is Why Absci Corp. (ABSI) is One of the Best Biotech Penny Stocks to Buy in...

Target launches new kind of supply chain facility

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Eaton (ETN) Announces a $30M Investment to Increase U.S. Switchgear Output

Eaton (ETN) Announces a $30M Investment to Increase U.S...

May 2, 2026

Jefferies, Barclays Cut Honeywell (HON) Targets After Q1, Flag Aerospace Concerns

Jefferies, Barclays Cut Honeywell (HON) Targets After Q...

May 2, 2026

NetApp’s Q4 2026 Earnings: What to Expect

NetApp’s Q4 2026 Earnings: What to Expect

Apr 25, 2026